Conflicting recommendations from Trump administration health officials have left health experts, vaccine makers and insurers uncertain about what to advise.

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce access to COVID-19 vaccines and restrict use to higher-risk populations. Here,